DNA Operating Cash Flow (Statement)
Ginkgo Bioworks Holdings Inc Class · Operating Cash Flow (Statement)
DNA Operating Cash Flow (Statement)
Latest reported-$170.24Mperiod ending
DNA Cash from Operations (-$44.66M → -$170.24M)
Annual operating cash flow (statement)
High-resolution chart · PNG
DNA operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -171,059,000 | |
| -319,585,000 | |
| -295,500,000 | |
| -252,198,000 | |
| -253,818,000 | |
| -135,830,000 | |
| -44,663,000 |